STONEPINE CAPITAL MANAGEMENT, LLC – Opiant Pharmaceuticals, Inc. Transaction History
STONEPINE CAPITAL MANAGEMENT, LLC portfolio value:
$1.63M
portfolio value
STONEPINE CAPITAL MANAGEMENT, LLC quarter portfolio value change:
-10.34%
quarter
Opiant Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -189K | $10.75 | 152.27K | |
| Q2 2022 | share | Increase | 0.00% | 152.27K shares | 1.82M | $11.99 | 152.27K |
| Q2 2020 | share | Decrease | -100.00% | -380.94K shares | -3.64M | $9.03 | 0 |
| Q1 2020 | share | Increase | +13.96% | 46.67K shares | -1.16M | $9.58 | 380.94K |
| Q4 2019 | share | Increase | +6.43% | 20.19K shares | 87K | $14.4 | 334.27K |
| Q3 2019 | share | Decrease | -0.44% | -1.39K shares | 547K | $15.05 | 314.07K |
| Q2 2019 | share | Increase | +6.98% | 20.57K shares | 311K | $13.25 | 315.46K |
| Q1 2019 | share | Decrease | -17.62% | -63.06K shares | -1.30M | $13.12 | 294.89K |
| Q4 2018 | share | Increase | +92.57% | 172.07K shares | 1.85M | $14.45 | 357.96K |
| Q3 2018 | share | Increase | 0.00% | 185.88K shares | 3.32M | $17.86 | 185.88K |